Alcoholism
FASgen Announces New Diagnostic Research Test for Steatohepatitis
Published in Hepatitis Weekly, June 18th, 2007
FASgen Inc. announced it has successfully expanded the potential use for its serum FAS (fatty acid synthase) ELISA diagnostic research test, FAS-Detect(TM) ELISA for the identification of Non-Alcoholic Steatohepatitis (NASH). The current diagnostic technique for this disease is a liver needle biopsy. While only for research use presently, FASgen anticipates the opportunity for use of the non-invasive FAS-Detect(TM) ELISA NASH test in the future will be substantial. FAS-Detect(TM) ELISA is a proprietary product of FASgen Diagnostics LLC, an affiliated FASgen company.
NASH commonly occurs as the result of fatty liver disease. Non-alcoholic fatty liver disease (NAFLD) is...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-06-18)
More Articles from Hepatitis Weekly
- Cancer Gene Therapy
Learn of the Use of Nanotechnology in Virology and its Potential for Antiviral Therapeutics - Hepatitis B Virus
AcroMetrix Receives 510(k) Clearance for VeriSure Pro HBV Blood Screening Controls - Hepatitis B Virus
Phase III Study Evaluating Gilead's Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint - Hepatitis C Virus
Amarillo CytoPharm to Conduct Hepatitis C Trial and Seek Regulatory Approval for Amarillo Biosciences' Low Dose Oral Interferon - Hepatitis C Virus
DiaSorin Provides Hepatitis Training for Laboratory and Healthcare Workers - Hepatitis C Virus
FierceBiotech Names Intarcia Therapeutics as One of the 'Fierce 15' Biotech Companies of 2007 - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
